Human CSF3/C17orf33/CSF3OS ORF/cDNA clone-Lentivirus particle (NM_000759)

Cat. No.: vGMLP004541

Pre-made Human CSF3/C17orf33/CSF3OS Lentiviral expression plasmid for CSF3 lentivirus packaging, CSF3 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.

The GM Vector Core (GMVC) specializes in custom lentivirus development and offers a range of lentivirus manufacturing solutions, leveraging state-of-the-art processes. Learn more about our services.

Target products collection

Go to G-CSF/CSF3/CSF3/C17orf33 products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdf MSDS
pdf Datasheet

Product information

Catalog No. Product Name lentivirus Grade lentivirus quantity
vGMLP004541 Human CSF3 Lentivirus particle Pilot Grade 1.0E+8TU
5.0E+8TU
1.0E+9TU
Research Grade 1.0E+8TU
5.0E+8TU
1.0E+9TU
GMP-like Grade inquiry
GMP Grade inquiry


Product Description

Catalog ID vGMLP004541
Gene Name CSF3
Accession Number NM_000759
Gene ID 1440
Species Human
Product Type Lentivirus particle (overexpression)
Insert Length 624 bp
Gene Alias C17orf33,CSF3OS,GCSF
Fluorescent Reporter ZsGreen
Mammalian Cell Selection Puromyocin
Fusion Tag 3xflag (C-Terminal)
Promoter CMV
Resistance Amplicin
ORF Nucleotide Sequence ATGGCTGGACCTGCCACCCAGAGCCCCATGAAGCTGATGGCCCTGCAGCTGCTGCTGTGGCACAGTGCACTCTGGACAGTGCAGGAAGCCACCCCCCTGGGCCCTGCCAGCTCCCTGCCCCAGAGCTTCCTGCTCAAGTGCTTAGAGCAAGTGAGGAAGATCCAGGGCGATGGCGCAGCGCTCCAGGAGAAGCTGGTGAGTGAGTGTGCCACCTACAAGCTGTGCCACCCCGAGGAGCTGGTGCTGCTCGGACACTCTCTGGGCATCCCCTGGGCTCCCCTGAGCAGCTGCCCCAGCCAGGCCCTGCAGCTGGCAGGCTGCTTGAGCCAACTCCATAGCGGCCTTTTCCTCTACCAGGGGCTCCTGCAGGCCCTGGAAGGGATCTCCCCCGAGTTGGGTCCCACCTTGGACACACTGCAGCTGGACGTCGCCGACTTTGCCACCACCATCTGGCAGCAGATGGAAGAACTGGGAATGGCCCCTGCCCTGCAGCCCACCCAGGGTGCCATGCCGGCCTTCGCCTCTGCTTTCCAGCGCCGGGCAGGAGGGGTCCTGGTTGCCTCCCATCTGCAGAGCTTCCTGGAGGTGTCGTACCGCGTTCTACGCCACCTTGCCCAGCCCTGA
ORF Protein Sequence MAGPATQSPMKLMALQLLLWHSALWTVQEATPLGPASSLPQSFLLKCLEQVRKIQGDGAALQEKLVSECATYKLCHPEELVLLGHSLGIPWAPLSSCPSQALQLAGCLSQLHSGLFLYQGLLQALEGISPELGPTLDTLQLDVADFATTIWQQMEELGMAPALQPTQGAMPAFASAFQRRAGGVLVASHLQSFLEVSYRVLRHLAQP

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Target Antibody GM-Tg-g-T19615-Ab Anti-CSF3/ C17orf33OS/ GCSF functional antibody
    Target Antigen GM-Tg-g-T19615-Ag CSF3 protein
    ORF Viral Vector pGMLP004541 Human CSF3 Lentivirus plasmid
    ORF Viral Vector vGMLP004541 Human CSF3 Lentivirus particle


    Target information

    Target ID GM-T19615
    Target Name G-CSF/CSF3
    Gene Group Identifier
    （Target Gene ID in Homo species)         		1440
    Gene ID 100033922 (Equus caballus), 12985 (Mus musculus), 1440 (Homo sapiens), 25610 (Rattus norvegicus)
    281096 (Bos taurus), 493700 (Felis catus), 608246 (Canis lupus familiaris), 698961 (Macaca mulatta)
    Gene Symbols & Synonyms CSF3,Csf3,G-CSF,Csfg,MGI-IG,GCSF,CSF3OS,C17orf33,Gcsf
    Target Alternative Names C17orf33,CSF3,CSF3OS,Csf3,Csfg,G-CSF,GCSF,Gcsf,Granulocyte colony-stimulating factor,MGI-IG,Pluripoietin
    Uniprot Accession O02708,P09919,P09920,P35833,P35834
    Additional SwissProt Accessions: P09920,P09919,P35833,O02708,P35834
    Uniprot Entry Name
    Protein Sub-location Secreted Protein/Potential Cytokines
    Category Therapeutics Target
    Disease metastatic tumors
    Disease from KEGG Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, JAK-STAT signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Malaria
    Gene Ensembl ENSECAG00000008668, ENSMUSG00000038067, ENSG00000108342, ENSBTAG00000021462, ENSCAFG00845010347, ENSMMUG00000002923
    Target Classification


    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.